Site Search:
Corporate Governance - Committee Composition
Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeCompensation CommitteeNominating and Corporate Governance Committee
Outside Directors
Wayne T. Hockmeyer, Ph.D. 
Wayne T. Hockmeyer, Ph.D.
Chairman of the Board


Wayne T. Hockmeyer, Ph.D. was appointed Chairman of the Board in November 2013 and has served as a director of GenVec since December 2000. Dr. Hockmeyer is a member of the Nominating and Corporate Governance Committee and is the Chairman of the Compensation Committee.

Dr. Hockmeyer founded MedImmune, Inc. in 1988. Dr. Hockmeyer earned his bachelor’s degree from Purdue University and his Ph.D. from the University of Florida in 1972. Dr. Hockmeyer was recognized in 1998 ... 

  Chairperson Committee Member
Zola P. Horovitz, Ph.D. 
Zola P. Horovitz, Ph.D.
Director


Zola P. Horovitz, Ph.D. joined the GenVec Board in August 2003. He is a member of the Nominating and Corporate Governance Committee and the Audit Committee.

Dr. Horovitz served as a director of Diacrin from 1994 to August 2003. Dr. Horovitz was Vice President, Business Development and Planning at Bristol-Myers Squibb Pharmaceutical Group from 1991 until 1994 and was Vice President, Licensing from 1989 to 1991. Prior to 1989, Dr. Horovitz spent 30 years as a member of the S... 

Committee Member   Committee Member
William N. Kelley, M.D.  
William N. Kelley, M.D.
Director


William N. Kelley, M.D. has served as a director of GenVec since June 2002. Dr. Kelley is a member of the Compensation Committee and is the Chairman of the Nominating and Corporate Governance Committee.

Dr. Kelley brings a long history of involvement in experimental models of gene therapy to the Board. Dr. Kelley and his colleagues at the University of Michigan were the first to propose in vivo gene therapy as it is recognized today and the first to directly administe... 

  Committee Member Chairperson
Stefan D. Loren, Ph.D. 
Stefan D. Loren, Ph.D.
Director


Stefan D. Loren, Ph.D. began serving as director of GenVec in September 2013. Dr. Loren is a member of the Audit Committee.

Dr. Loren is the founder of LCS, a strategic investment firm focused on life science companies. Most recently, he headed the life science practice of Westwicke Partners, a healthcare-focused consulting firm. Prior to joining Westwicke, he worked as an Analyst/Portfolio Manager with Perceptive Advisors, a health care hedge fund, and MTB Investment Advisors, ... 

Committee Member   
Marc R. Schneebaum  
Marc R. Schneebaum
Director


Marc R. Schneebaum joined the GenVec Board in April 2007. He is a member of the Compensation Committee and is the Chairman of the Audit Committee.

Recently, Mr. Schneebaum served as Chief Executive Officer of Predictive BioSciences, Inc., a commercial stage, cancer diagnostics company. From 1997 to 2010 Mr. Schneebaum served as President, CEO and a director of Sensors for Medicine and Science, Inc. (SMSI), an emerging medical technology company. Previously, he served as Senior ... 

Chairperson Committee Member  

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
GNVC (Common)
ExchangeNASDAQ CM (US Dollar)
Price$2.08
Change (%)0.00 (0.00%)
Volume18,847
Data as of 08/29/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Print This Page | Bookmark this Page
home